関連する実験動画
Updated: Jul 10, 2026
10:34
A High-content Assay for Monitoring AMPA Receptor Trafficking
Published on: January 28, 2019
TARP補助サブユニットは,AMPA受容体アンタゴニストを部分アゴニストに切り替えます
Karen Menuz1, Robert M Stroud, Roger A Nicoll
1Department of Cellular and Molecular Pharmacology, University of California at San Francisco, San Francisco, CA 94143, USA.
Science (New York, N.Y.)
|November 3, 2007
まとめ
一般的なAMPA受容体対抗体であるCNQXは,外膜AMPA受容体調節タンパク質 (TARP) が存在すると,部分的アゴニストとして作用する. TARPはCNQXを強化する
科学分野:
- 神経科学は神経科学である.
- 分子生物学は分子生物学である.
- 薬理学 薬理学とは
背景:
- 6-シアノ-7-ニトロキノキノキサリン-2,3-ダイオン (CNQX) のようなキノキサリンジオン化合物は,アルファ-アミノ-3-ヒドロキシ-5-メチル-4-イソクサゾロプロピオン酸 (AMPA) 受容体抗体として広く使用されています.
- トランス膜AMPA受容体調節タンパク質 (TARP) は,AMPA受容体の機能を調節する重要な補助サブユニットです.
研究 の 目的:
- AMPA受容体におけるCNQXの活性を調節するTARPの機能的役割を調査する.
- TARPがCNQXのアゴニスト/アンタゴニスト特性に影響するメカニズムを解明する.
主な方法:
- CNQX誘発電流を測定するために,中枢神経系のニューロンにおける電気生理学的記録.
- AMPA受容体とTARPを対象とした同発現の研究.
- TARPのないAMPA受容体のリガンド結合ドメインに結合するCNQXの結晶構造分析.
主要な成果:
- CNQXはニューロンの小さな脱極化電流を誘導し,TARPの存在下での部分的アゴニスト活性を示した.
- このアゴニストの活動は,TARPsの共発現に依存していた.
- 結晶構造は,TARPが存在しない場合,CNQXが部分的なドメイン閉鎖を引き起こすが,これはチャネル開封に変換されないことを明らかにし,TARPがこのカップリングを強化することを示唆した.
結論:
- AMPA受容体補助サブユニット (TARP) の存在は,化合物の薬理学的プロフィールを根本的に変化させ,抗体から部分的アゴニストに切り替えることができます.
- TARPは,チャネルゲートへのリガンド結合の伝導を改善することによって,部分アゴニストの有効性を高める上で重要な役割を果たします.
さらに関連する動画
07:41A Kinetic Fluorescence-based Ca2+ Mobilization Assay to Identify G Protein-coupled Receptor Agonists, Antagonists, and Allosteric Modulators
Published on: February 20, 2018
07:16Methods for the Discovery of Novel Compounds Modulating a Gamma-Aminobutyric Acid Receptor Type A Neurotransmission
Published on: August 16, 2018
関連する概念動画
01:31Adrenergic Receptors: ɑ Subtype
Adrenoceptors are classified into α and ꞵ classes based on their potencies to catecholamine agonists. α-adrenoceptors show the following order of catecholamine potency:
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase C—inositol-1,4,5-trisphosphate...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
01:30Ligand-Gated Ion Channel Receptor: Gating Mechanism
Ligand-gated ion channels are transmembrane proteins that play a vital role in intercellular communication and functions of the nervous system. They allow the influx of ions across the membrane once the neurotransmitter binds, allowing the subsequent transmission of electrical excitation across the neurons. Other ligand-gated ion channels, like the γ-aminobutyric acid (GABA) receptor, permit anions like chloride into the cells on the binding of the GABA molecule. Their entry into the cell...
01:20Desensitization and Tachyphylaxis
Tachyphylaxis is described as a rapid decrease in response to a drug after repeated or continuous administration of the same drug dose. It is a phenomenon where the body becomes less responsive to a particular substance or intervention over time, requiring higher doses or stronger interventions to achieve the same effect. It results from adaptive changes in the body's receptors, signaling pathways, or physiological processes that occur in response to prolonged exposure to a stimulus.
Several...
Several...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:22Opioid Receptors: Overview
Opioid receptors, including the mu (μ, MOR), delta (δ, DOR), and kappa (κ, KOR) types, belong to the rhodopsin family of G protein-coupled receptors. These receptors are located throughout the central and peripheral nervous systems and in non-neuronal tissues such as macrophages and astrocytes. Opioid receptor ligands can be categorized into agonists or antagonists. Highly selective agonists include [d-Ala2, MePhe4, Gly(ol)5]-enkephalin or DAMGO for MOR, [D-Pen2, D-Pen5]-enkephalin or DPDPE for...